Abstract

Facklamia is a genus of Gram-positive, facultatively anaerobic cocci, first identified in 1997. These bacteria are part of the family Aerococcaceae, closely related to other lactic acid bacteria in the order Lactobacillales. The genus currently includes species like Facklamia hominis, Facklamia ignava, and Facklamia languida, which are often found in human clinical samples including blood, cerebrospinal fluid, and wounds. While typically harmless in healthy individuals, Facklamia infections can lead to serious complications in immunocompromised patients or those with underlying conditions and are implicated in infections such as bacteremia, paendocarditis, and chorioamnionitis. The recognition of Facklamia in clinical settings has grown, necessitating more research into their epidemiology and significance. Facklamia species are catalase-negative and typically form small chains or clusters. Accurate identification of these bacteria is critical due to their close resemblance to other cocci, such as Streptococci, under a microscope. The pathogenic mechanisms of Facklamia are not fully understood, but they are increasingly associated with nosocomial infections, particularly in vulnerable patient populations. Accurate diagnostic methods and awareness of Facklamia's pathogenic potential are critical for effective treatment.